IBDEI349 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,49775,0)
 ;;=F43.11^^193^2482^59
 ;;^UTILITY(U,$J,358.3,49775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49775,1,3,0)
 ;;=3^PTSD,Acute
 ;;^UTILITY(U,$J,358.3,49775,1,4,0)
 ;;=4^F43.11
 ;;^UTILITY(U,$J,358.3,49775,2)
 ;;=^5003571
 ;;^UTILITY(U,$J,358.3,49776,0)
 ;;=F43.12^^193^2482^60
 ;;^UTILITY(U,$J,358.3,49776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49776,1,3,0)
 ;;=3^PTSD,Chronic
 ;;^UTILITY(U,$J,358.3,49776,1,4,0)
 ;;=4^F43.12
 ;;^UTILITY(U,$J,358.3,49776,2)
 ;;=^5003572
 ;;^UTILITY(U,$J,358.3,49777,0)
 ;;=I25.119^^193^2482^5
 ;;^UTILITY(U,$J,358.3,49777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49777,1,3,0)
 ;;=3^Athscl Hrt Dis of Native Cor Art w/ Ang Pctrs,Unspec
 ;;^UTILITY(U,$J,358.3,49777,1,4,0)
 ;;=4^I25.119
 ;;^UTILITY(U,$J,358.3,49777,2)
 ;;=^5007111
 ;;^UTILITY(U,$J,358.3,49778,0)
 ;;=I25.10^^193^2482^6
 ;;^UTILITY(U,$J,358.3,49778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49778,1,3,0)
 ;;=3^Athscl Hrt Dis of Native Cor Art w/o Ang Pctrs
 ;;^UTILITY(U,$J,358.3,49778,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,49778,2)
 ;;=^5007107
 ;;^UTILITY(U,$J,358.3,49779,0)
 ;;=F17.219^^193^2482^49
 ;;^UTILITY(U,$J,358.3,49779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49779,1,3,0)
 ;;=3^Nicotine Dependence,Cigarettes
 ;;^UTILITY(U,$J,358.3,49779,1,4,0)
 ;;=4^F17.219
 ;;^UTILITY(U,$J,358.3,49779,2)
 ;;=^5003369
 ;;^UTILITY(U,$J,358.3,49780,0)
 ;;=Z51.5^^193^2482^62
 ;;^UTILITY(U,$J,358.3,49780,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49780,1,3,0)
 ;;=3^Palliative Care Encounter
 ;;^UTILITY(U,$J,358.3,49780,1,4,0)
 ;;=4^Z51.5
 ;;^UTILITY(U,$J,358.3,49780,2)
 ;;=^5063063
 ;;^UTILITY(U,$J,358.3,49781,0)
 ;;=Z23.^^193^2482^26
 ;;^UTILITY(U,$J,358.3,49781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49781,1,3,0)
 ;;=3^Encounter for Immunization(s)
 ;;^UTILITY(U,$J,358.3,49781,1,4,0)
 ;;=4^Z23.
 ;;^UTILITY(U,$J,358.3,49781,2)
 ;;=^5062795
 ;;^UTILITY(U,$J,358.3,49782,0)
 ;;=E11.65^^193^2482^18
 ;;^UTILITY(U,$J,358.3,49782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49782,1,3,0)
 ;;=3^DM Type 2 Uncontrolled w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,49782,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,49782,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,49783,0)
 ;;=E11.649^^193^2482^19
 ;;^UTILITY(U,$J,358.3,49783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49783,1,3,0)
 ;;=3^DM Type 2 Uncontrolled w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,49783,1,4,0)
 ;;=4^E11.649
 ;;^UTILITY(U,$J,358.3,49783,2)
 ;;=^5002662
 ;;^UTILITY(U,$J,358.3,49784,0)
 ;;=I16.0^^193^2482^42
 ;;^UTILITY(U,$J,358.3,49784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49784,1,3,0)
 ;;=3^Hypertensive Urgency
 ;;^UTILITY(U,$J,358.3,49784,1,4,0)
 ;;=4^I16.0
 ;;^UTILITY(U,$J,358.3,49784,2)
 ;;=^8133013
 ;;^UTILITY(U,$J,358.3,49785,0)
 ;;=H54.8^^193^2482^45
 ;;^UTILITY(U,$J,358.3,49785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49785,1,3,0)
 ;;=3^Legal Blindness,USA Definition
 ;;^UTILITY(U,$J,358.3,49785,1,4,0)
 ;;=4^H54.8
 ;;^UTILITY(U,$J,358.3,49785,2)
 ;;=^5006369
 ;;^UTILITY(U,$J,358.3,49786,0)
 ;;=F10.10^^193^2482^2
 ;;^UTILITY(U,$J,358.3,49786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49786,1,3,0)
 ;;=3^Alcohol Abuse,Uncomplicated
 ;;^UTILITY(U,$J,358.3,49786,1,4,0)
 ;;=4^F10.10
 ;;^UTILITY(U,$J,358.3,49786,2)
 ;;=^5003068
 ;;^UTILITY(U,$J,358.3,49787,0)
 ;;=J30.9^^193^2482^3
 ;;^UTILITY(U,$J,358.3,49787,1,0)
 ;;=^358.31IA^4^2
